Skip to main content
ROIV logo

Roivant Sciences Ltd.

ROIVNASDAQHealthcareBiotechnology

$33.53Today:- (-)1Y +97.22%

As of Oct 16, 2026 close

Market cap
$24.54B
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$16.41$42.50
Volume (live)
-
Avg. volume (3M)
7.68M

Roivant Sciences (ROIV) Financial Ratios

For fiscal 2026 (fiscal year ended Mar 31, 2026), Roivant Sciences had return on equity of -7.6% (up from -12.5%), debt-to-equity of 0.02 (up from 0.02), a current ratio of 18.37 (down from 33.47) and return on assets of -14.3% (down from -10.7%). A current ratio of 18.37 means current assets exceed current liabilities.

Roivant Sciences Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2026FY 2025FY 2024FY 2023FY 2022FY 2021
Period endingMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Valuation Ratios
P/E Ratio--1.95---7.64
P/S Ratio2400.11247.81259.64177.5261.84267.81
P/B Ratio3.751.391.323.481.663.54
Price/Tangible Book4.381.541.425.532.063.43
Price/FCF------11.42
Price/OCF------11.54
Enterprise Value Ratios
EV/Revenue1950.2286.0586.33159.2534.11202.32
EV/EBITDA------4.50
EV/EBIT------4.50
EV/FCF------8.63
Profitability & Returns
Return on Equity (ROE)-7.59%-12.54%112.87%-48.46%-44.82%-43.17%
Return on Assets (ROA)-14.35%-10.73%-10.14%-20.33%-20.26%-42.35%
Return on Invested Capital (ROIC)-169.69%-532.64%-369.64%-232.11%-312.50%-329.07%
Return on Capital Employed (ROCE)-23.60%-20.60%-11.20%-38.20%-34.90%-45.04%
Leverage & Solvency Ratios
Debt/Equity0.020.020.010.300.140.11
Debt/EBITDA------0.23
Debt/FCF------0.44
Liquidity Ratios
Current Ratio18.3733.4725.246.6011.649.99
Quick Ratio15.2632.7124.356.2911.219.39
Efficiency Ratios
Asset Turnover0.000.010.010.010.020.01
Yield & Distribution Ratios
Earnings Yield-1.51%-2.39%51.20%-18.03%-24.72%-13.09%
FCF Yield-3.83%-11.72%-9.03%-15.29%-20.33%-8.76%
Buyback Yield4.35%12.71%-16.59%-6.43%-6.30%1.70%
Total Return-----1.70%

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Roivant Sciences Financial Ratios

What is Roivant Sciences's return on equity?

Roivant Sciences's return on equity (ROE) was -7.6% for fiscal 2026 (period ended Mar 31, 2026). It was -12.5% a year earlier.

What is Roivant Sciences's debt-to-equity ratio?

Roivant Sciences's debt-to-equity ratio was 0.02 for fiscal 2026 (period ended Mar 31, 2026). It was 0.02 a year earlier.

What is return on equity (ROE)?

Return on equity is net income divided by shareholders' equity. It measures how much profit a company generates from the capital its shareholders have invested. Full definition